mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists - Wikidata - wikimedia - TriplyDB

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

http://www.wikidata.org/entity/Q29618120

about

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants Neuroplasticity and the next wave of antidepressant strategies Preclinical evidence of rapid-onset antidepressant-like effect in Radix Polygalae extract Ketamine and other glutamate receptor modulators for depression in adults A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder Rapid antidepressant effects: moving right along mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade An emerging role for TOR signaling in mammalian tissue and stem cell physiology Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Pharmacological treatment of PTSD - established and new approaches To use or not to use: an update on licit and illicit ketamine use Potential Roles of Adropin in Central Nervous System: Review of Current Literature Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review Ketamine enantiomers in the rapid and sustained antidepressant effects Practical application of the neuroregenerative properties of ketamine: real world treatment experience Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist Linking Mitochondria to Synapses: New Insights for Stress-Related Neuropsychiatric Disorders Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness Dendritic Spines in Depression: What We Learned from Animal Models Stress as a one-armed bandit: Differential effects of stress paradigms on the morphology, neurochemistry and behavior in the rodent amygdala.Depression as a Glial-Based Synaptic Dysfunction Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)'s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression Legal highs: staying on top of the flood of novel psychoactive substances Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine Antidepressant mechanism of ketamine: perspective from preclinical studies Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review The neurology of mTOR Stress-induced deficits in cognition and emotionality: a role of glutamate Ketamine, sleep, and depression: current status and new questions Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments Review of pharmacological treatment in mood disorders and future directions for drug development.The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

P2860

Q21129276-ADD4A3F6-9FE4-4BE3-866C-E1E2097E4023 Q21129480-8680112F-E2A2-48D5-939E-D0A669A863EB Q21132322-51697A54-8F05-4FFA-A4FE-5A70183C98E8 Q24186746-1E3D7C4D-D9E0-4C1A-99A9-1A76B63B71CA Q24602988-A14476A8-F528-4643-B7BE-31E6D37FD076 Q24614410-E6A1FDE6-D34D-4F71-915D-8E9603533F19 Q24617166-88CBEB33-F301-4109-9B8D-D2C5D535A4E1 Q24629305-282A0454-383B-443D-B739-CEE87B2A939E Q24629398-9CAD8849-970C-4469-B278-9CD0128A49DD Q24629780-560C3B24-7AFE-440B-B550-1F560564C168 Q24630584-420AAFAC-1194-4BEB-A898-D006C82B86C7 Q24632936-13872E48-920A-4F9E-B198-4AA18A9872D5 Q24633256-1B1801F5-6623-4963-8900-DC6395E29A52 Q24634006-BBE3B687-1B60-4CB3-8519-90967FCDC778 Q26742073-CA6845BF-840D-4CFD-80ED-9C6C8F5E7BEE Q26743786-CACFC6A9-9FFA-4B75-B896-D607395B6B9D Q26746141-F08040BC-D0B7-4264-B513-E5323C820AEE Q26748766-A617F17E-0E2E-4350-A8F6-9EAC432C3A7E Q26750021-D702C624-3D8D-442C-A901-EA58BF927F96 Q26765236-77492626-5D6B-4E93-9FAB-0CA362277A22 Q26765501-993A9DAF-0209-4448-8185-C4E7DA434F9B Q26765612-E8CF817C-EBA3-458D-A864-721B1851CF26 Q26769043-266C6E1C-590A-461D-9826-9D12BA73448F Q26772830-6FC2C095-85DF-47C8-8989-7D7ADA794493 Q26773084-561C5E04-C52B-454F-A44B-B2498967503C Q26778251-24FD99B6-9B2A-45A8-B87E-7AEB5B8AA949 Q26782274-02474EE0-0AE4-437C-AF7D-474B2DCA430E Q26786354-6CF0717E-C459-41C4-835A-974C8C15782A Q26796248-D911656C-EAE0-4748-88D9-86E2D5F691C1 Q26799231-95DC13CC-0B58-4B7F-A4F6-5D199B3D6CA1 Q26799619-D8B746AA-FF11-4496-AA71-9632BDEA5ADF Q26800231-E27178EA-B2FA-4F2A-8D9A-D884A1AD22BF Q26820417-D92662FD-4BCB-4435-94B6-22048D59EAD4 Q26822244-13DA700C-2029-49B9-90C9-6431F882435E Q26824286-54C7DA40-8779-46AE-AD71-DF231CD6840A Q26825021-8CBB911C-37FE-4A47-BA76-E4624E84D091 Q26828564-26C43626-6965-454C-9A84-4BB3E37F48A6 Q26850307-47E82E86-980A-43BF-8231-F27199D22C26 Q26853509-47DB9CC7-7A9E-4092-B0AE-74AE226450F8 Q26859198-30B1B801-E4FC-4423-8DF7-3BDBC62D7A9B

P2860

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

http://www.wikidata.org/entity/Q29618120

description

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Science

@fr

artículu científicu espublizáu en 2010

@ast

im August 2010 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 20 August 2010)

@en

wetenschappelijk artikel (gepubliceerd op 2010/08/20)

@nl

наукова стаття, опублікована в серпні 2010

@uk

مقالة علمية (نشرت في 20-8-2010)

@ar

name

mTOR-dependent synapse formati ...... nt effects of NMDA antagonists

@ast

mTOR-dependent synapse formati ...... nt effects of NMDA antagonists

@en

type

label

mTOR-dependent synapse formati ...... nt effects of NMDA antagonists

@ast

mTOR-dependent synapse formati ...... nt effects of NMDA antagonists

@en

prefLabel

mTOR-dependent synapse formati ...... nt effects of NMDA antagonists

@ast

mTOR-dependent synapse formati ...... nt effects of NMDA antagonists

@en

P1433

Q29618120-9FA86437-738B-43F8-82EE-BB0AF3807C3B

P1476

Q29618120-6F71D1E3-CA42-4926-996F-CBA68BA52B19

P2093

Q29618120-0ED1BC37-A14F-443A-8810-46E19F8B31C6

Q29618120-21630112-69CA-4D61-B158-01B67E894EB2

Q29618120-37AB441A-7D2F-449D-99F1-165FE10A295E

Q29618120-4CD149D2-BFFD-410F-8340-4C7BA99EB91B

Q29618120-550D1920-4C5F-40BB-8A52-017AB75D0758

Q29618120-86342752-F3BC-485D-B6D6-364835F08A1A

Q29618120-AE84622B-9141-459C-9497-E2303F282715

Q29618120-C0F26BCD-CA84-4815-B939-5CB3C9CDE0C6

P2860

Q29618120-0095EA40-CE21-4FD7-BA55-13276A4F0033

Q29618120-2A9FB5E2-C650-45FA-98DD-71A6D2FB5537

Q29618120-3B896C03-B043-4BD1-B937-FF0E0D2999A6

Q29618120-4872E6EB-5F1E-4122-8BBD-81ADE48CF1BD

Q29618120-572E846E-DBE6-465D-A4D5-A5EE3DEDE3D0

Q29618120-6155B1AF-3652-4489-BC09-74958B7299BB

Q29618120-753BE176-B8F4-43CD-83CD-BD66C8078890

Q29618120-7D93F849-FC54-4594-A59A-37570608B0E9

Q29618120-82004B59-8A40-4F76-8B61-A29C10765DB7

Q29618120-9782C93B-7EB7-4BE9-AFDB-2756BC6B2C7C

P304

Q29618120-199B7799-3208-4938-8CC3-CE89CC53478C

P31

Q29618120-61257A4F-AF71-4B46-B9BB-120603B4EBF9

P3181

Q29618120-EECC7F86-2C1D-450B-8CBE-DDB5D4B8C3EF

P356

Q29618120-DA804C7F-8BC7-4D9D-89A0-983F158609A9

P407

Q29618120-C79D80B5-68DA-4026-9564-3D8F5F83EC62

P433

Q29618120-0A6C4E47-1022-4AC0-A4F0-D85F9DEFC7FB

P478

Q29618120-31F31BE9-08E1-4A1D-B53D-906BC130112B

P50

Q29618120-2912C7C4-CE68-451D-A82A-93265BEC5AB0

P577

Q29618120-42D147AE-5E44-403E-8626-C2F5C6FAD59E

P5875

Q29618120-2F3398F5-1A6D-475D-82EC-B6243023EA06

P698

Q29618120-B6CC2943-1462-45B6-AF9D-67656A2568B7

P932

Q29618120-EB1A3008-2F40-405B-8280-2FD9298C4610

P3181

P356

SCIENCE.1190287

P1433

P1476

mTOR-dependent synapse formati ...... nt effects of NMDA antagonists

@en

P2093

Boyoung Lee

http://www.w3.org/2001/XMLSchema#string

George Aghajanian

http://www.w3.org/2001/XMLSchema#string

Jason M Dwyer

http://www.w3.org/2001/XMLSchema#string

Mounira Banasr

http://www.w3.org/2001/XMLSchema#string

Nanxin Li

http://www.w3.org/2001/XMLSchema#string

Ronald S Duman

http://www.w3.org/2001/XMLSchema#string

Rong-Jian Liu

http://www.w3.org/2001/XMLSchema#string

Xiao-Yuan Li

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR signaling: at the crossroads of plasticity, memory and disease

Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Antidepressant effects of ketamine in depressed patients

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Functional neuroimaging studies of depression: the anatomy of melancholia.

Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation.

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

Dendritic spine formation and stabilization.

P304

959-964

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

312825

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1190287

http://www.w3.org/2001/XMLSchema#string

P407

P433

5994

http://www.w3.org/2001/XMLSchema#string

P478

329

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45720992

http://www.w3.org/2001/XMLSchema#string

P698

20724638

http://www.w3.org/2001/XMLSchema#string

P932

3116441

http://www.w3.org/2001/XMLSchema#string